Malignant Melanoma

Facial Plastic Surgery Clinics of North America

Volumn 17, Issue 3, 2009, Pages 337-348

  Califano, Joseph ^a,b   Nance, Melonie ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cutaneous neoplasm; Diagnosis; Incidence; Malignant melanoma; Sentinel lymph node biopsy; Skin cancer; Treatment

Indexed keywords

ALPHA2B INTERFERON; CANCER VACCINE; CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; PACLITAXEL;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DISTANT METASTASIS; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALIGNANT LENTIGO; MELANOMA; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; SUN EXPOSURE; SURVIVAL RATE; ULTRAVIOLET RADIATION;

BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 68849117777     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2009.05.002     Document Type: Review

References (32)

1. Abbasi N.R., Shaw H.M., Rigel D.S., et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 292 (2004) 2771-2776
2. de Snoo F.A., Bergman W., and Gruis N.A. Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer 2 (2003) 109-116
3. Goldstein A.M., and Tucker M.A. Genetic epidemiology of familial melanoma. Dermatol Clin 13 (1995) 605-612
4. Wenig B.M. Atlas of head and neck pathology (1993), Saunders, Philadelphia
5. Swetter S. Malignant melanoma. Available at:. http://emedicine.medscape.com/article/1100753-diagnosis Accessed February 12, 2009
6. Geller A.C., Miller D.R., Annas G.D., et al. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288 (2002) 1719-1720
7. Bailey B.J., Johnson J.T., and Newlands S. Head and neck surgery - otolaryngology. 3rd edition (2006), Lippincot, Williams, and Wilkins, Philadelphia
8. Friedman R.J., Rigel D.S., Silverman M.K., et al. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin 41 (1991) 201-226
9. Grob J.J., and Bonerandi J.J. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol 134 (1998) 103-104
10. Miracco C., Santopietro R., Biagioli M., et al. Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. J Cutan Pathol 25 (1998) 244-251
11. Sasaki Y., Niu C., Makino R., et al. BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol 123 (2004) 177-183
12. Coit DG, editor. The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (TM) MELANOMA (Version 2.2009) Copyright 2009 NCCN, Inc. Available at: http://www.nccn.org. Accessed January 21, 2009.
13. Buzaid A.C., Tinoco L.A., Jendiroba D., et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 13 (1995) 2361-2368
14. Mariani G., Erba P., Manca G., et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J Surg Oncol 85 (2004) 141-151
15. Morris K.T., Busam K.J., Bero S., et al. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy. Ann Surg Oncol 15 (2008) 316-322
16. Morton D.L., Cochran A.J., Thompson J.F., et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005) 302-311 [discussion: 311-3]
17. Thompson J.F., and Shaw H.M. Sentinel node mapping for melanoma: results of trials and current applications. Surg Oncol Clin N Am 16 (2007) 35-54
18. Wong S.L. Surveillance chest X-rays for melanoma: prescription or proscription?. Ann Surg Oncol 16 (2009) 552-553
19. Bleicher R.J., Kloth D.D., Robinson D., et al. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 99 (2009) 356-360
20. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
21. Balch C.M., Soong S.J., Smith T., et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 8 (2001) 101-108
22. Zitelli J.A., Moy R.L., and Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 24 (1991) 102-106
23. Bricca G.M., Brodland D.G., Ren D., et al. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 52 (2005) 92-100
24. Balch C.M. Randomized surgical trials involving elective node dissection for melanoma. Adv Surg 32 (1999) 255-270
25. Desmond R.A., and Soong S.J. Epidemiology of malignant melanoma. Surg Clin North Am 83 (2003) 1-29
26. Ballo M.T., and Ang K.K. Radiation therapy for malignant melanoma. Surg Clin North Am 83 (2003) 323-342
27. Manola J., Atkins M., Ibrahim J., et al. Prognostic factors in metastatic melanoma: a pooled analysis of eastern cooperative oncology group trials. J Clin Oncol 18 (2000) 3782-3793
28. Sirott M.N., Bajorin D.F., Wong G.Y., et al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 72 (1993) 3091-3098
29. Unger J.M., Flaherty L.E., Liu P.Y., et al. Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 91 (2001) 1148-1155
30. Barth A., Wanek L.A., and Morton D.L. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 181 (1995) 193-201
31. Polsky D., Young A.Z., Busam K.J., et al. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res 61 (2001) 6008-6011
32. Katipamula R., and Markovic S.N. Emerging therapies for melanoma. Expert Rev Anticancer Ther 8 (2008) 553-560